Skip to content

Clinical trials

Phase 3 Myocardial Ischemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Ischemia Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20042
20053
20062
20071
20082
20092
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices2
Mayo Clinic2
Sanofi2
US Department of Veterans Affairs2
Abiomed Inc.1
Amarin Pharma Inc.1
Cardiovascular Research Foundation, New York1
Cogentus Pharmaceuticals1
Columbia University1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Ischemia19
Heart Diseases6
Myocardial Infarction6
Acute Coronary Syndrome5
Coronary Artery Disease5
Ischemia4
Vascular Diseases4
Arterial Occlusive Diseases3
Arteriosclerosis3
Coronary Disease3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.